CLINICAL_TRIALS
trial_result
· 2022-05-18
Clinical Trial Update: Evaluating the Efficacy of Intranasal Oxytocin Among Individuals With Persistent Pain [Phase 2, Phase 3]
Summary
Phase 2/3 trial evaluating intranasal oxytocin for chronic and pelvic pain has completed.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: University of Calgary | Conditions: Chronic Pain, Pelvic Pain | Phase 2, Phase 3 | Status: COMPLETED